At Broadstreet we deliver solutions not formulas.
An open-minded and client-focused approach means our customized design process delivers the solution you need.
Broadstreet is a boutique technology solutions company for the health economics and outcomes research community. We were founded on the idea that good research begins with a solid client-consultant relationship. We consistently deliver high-quality technology solutions for two key reasons.
We only take on work we know we’re great at and, more importantly, we put the client at the center of the process.
Epidemiology & Observational Studies
Our team designs and conducts observational studies used to characterize the clinical landscape and burden of disease for a product’s indication; estimate treatment effectiveness or safety; or parameterize economic models.
We provide rigorously conducted literature reviews following best practices guidelines, coupled with robust quantitative or qualitative evidence syntheses, to address a variety of research questions.
Our team develops HEOR models for a variety of contexts and settings. Our approach to model development and adaptation is to work with clients to design a customized structure and interface, in accordance with submission requirements and guidelines for best practice.
HEOR Technology Services
We have the IT capability to undertake big solutions. We create a variety of high-quality, custom digital products for our clients. These include tools that ensure for timely and accurate data collection, digital models that facilitate data analysis, and novel tools for dissemination of study findings.
Sunday is Rare Disease Day! The last day of every February is dedicated to raising awareness among the general public and decision-makers about rare diseases, and their impact on patients’ lives. This is a cause near and dear to our […]
What’s in a name? How about a constant reminder of the ethos that inspires Broadstreet. As we start 2021 full of hope for a better year than the last, at Broadstreet we have been reflecting on the key contributions epidemiology […]
This has been a difficult year for everyone. However, Broadstreet has been fortunate in many ways and I thought it would be nice to end the year on a positive note, reflecting on all the things that we have […]